Abstract
CRISPR/Cas9-mediated genome editing technology consists of a single-guide RNA (sgRNA), and the Cas9 endonuclease has the potential to treat genetic diseases in most tissues and organisms. In this system, the Cas9 protein can be directed to target genomic DNA sequences as “molecular scissors” with the guidance of sgRNAs. However, the target-specific activities of different sgRNAs are highly variable; thus, it is crucial to search for a simple, quick and economical method to screen for optimized sgRNAs with high target specificity. We have adopted and verified a newly developed white-to-blue colony formation assay to quickly screen for sgRNAs optimized for the EphA2 gene, which is highly expressed in hormone-resistant prostate cancer (PC-3) cells. This assay promises to screen for optimized sgRNAs more simply, rapidly, and efficiently. Our results suggest that the white-to-blue colony formation assay might be a useful screening strategy to quickly select for optimized sgRNAs.
Similar content being viewed by others
References
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013). Genome engineering using the CRISPR-Cas9 system. Nature Biotechnology, 8, 2281–2308.
Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Tsai, S. Q., Sander, J. D., et al. (2013). Efficient genome editing in zebrafish using a CRISPR-Cas system. Nature Biotechnology, 31, 227–229.
Chang, N., Sun, C., Gao, L., Zhu, D., Xu, X., Zhu, X., et al. (2013). Genome editing with RNA-guided Cas9 nuclease in zebrafish embryo. Cell Research, 23, 465–472.
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., et al. (2013). RNA-Guided human genome engineering via Cas9. Science, 339, 823–826.
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 337, 816–821.
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., et al. (2013). DNA targeting specificity of RNA-guided Cas9 nucleases. Nature Biotechnology, 31, 827–832.
Kleinstiver, B. P., Prew, M. S., Tsai, S. Q., Topkar, W., Nguyen, N. T., Zhang, Z., et al. (2015). Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature, 523, 481–485.
Jinek, M., East, A., Cheng, A., Lin, S., Ma, E., & Doudna, J. (2013). RNA-programmed genome editing in human cells. Elife, 2, e00471.
Bian, S., Zhou, Y., Hu, Y., Cheng, J., Chen, X., Xu, Y., & Liu, P. (2017). High-throughput in situ cell electroporation microsystem for parallel delivery of single guide RNAs into mammalian cells. Scientific Reports, 7, 42512.
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., et al. (2015). Guide-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nature Biotechnology, 33, 187–197.
Kim, D., Bae, S., Park, J., Kim, E., Kim, S., Yu, H. R., et al. (2015). Digenome-seq: Genome-wide profiling of CRISPR-Cas9 off-target effects on human cells. Nature Methods, 12, 237–243.
Vouillot, L., Thelie, A., & Pollet, N. (2015). Comparison of T7E1 and surveyor mismatch cleavage assays to detect mutations triggered by engineered nucleases. G3(Bethesda), 5, 407–415.
Zhang, H., Zhang, X., Fan, C., Xie, Q., Xu, C., Zhao, Q., et al. (2016). A novel sgRNA selection system for CRISPR-Cas9 in mammalian cells. Biochemical and Biophysical Research Communications, 471, 528–532.
Carrington, B., Varshney, G. K., Burgess, S. M., & Sood, R. (2015). CRISPR-STAT: An easy and reliable PCR-based method to evaluate target-specific sgRNA activity. Nucleic Acids Research, 43, e157.
Feldman, B. J., & Feldman, D. (2001). The development of androgen-independent prostate cancer. Nature Reviews Cancer, 1, 34–45.
Kullander, K., & Klein, R. (2002). Mechanisms and functions of Eph and ephrin signalling. Nature Reviews Molecular Cell Biology, 3, 475–486.
Pasquale, E. B. (1997). The Eph family of receptors. Current Opinion in Cell Biology, 9, 608–615.
Tandon, M., Vemula, S. V., & Mittal, S. K. (2011). Emerging strategies for EphA2 receptor targeting for cancer therapeutics. Expert Opinion on Therapeutic Targets, 15, 31–51.
Lisle, J. E., Mertens-Walker, I., Rutkowski, R., Herington, A. C., & Stephenson, S. A. (1835). Eph receptors and their ligands: Promising molecular biomarkers and therapeutic targets in prostate cancer. Biochimica et BiophysicaActa, 2013, 243–257.
Walker-Daniels, J., Coffman, K., Azimi, M., Rhim, J. S., Bostwick, D. G., Snyder, P., et al. (1999). Overexpression of the EphA2 tyrosine kinase in prostate cancer. Prostate, 41, 275–280.
Brinkman, E. K., Chen, T., Amendola, M., & van Steensel, B. (2014). Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Research, 42, e168.
Zhou, L., Wang, Q., & Li, K. (2016). Construction of a vector with two repeats flanking CRISPR/Cas9 target for the evaluation of enzymatic activity in E. coli. Journal of Nanoscience & Nanotechnology, 16, 12332–12336.
Wang, Q., Xiao, L., Zhou, L., Sun, W. P., Xing, C. G., Li, K., & He, N. Y. (2018). Comparison of the off-target effects among one-base to three-base mismatched targets of gRNA using a blue to white assay. Journal of Nanoscience & Nanotechnology, 18, 1594–1598.
Yin, Y. F., Wang, Q., Xiao, L., Wang, F. J., Song, Z., Zhou, C. L., et al. (2018). Advances in the engineering of the gene editing enzymes and the genomes: Understanding and handling the off-target effects of CRISPR/Cas9. Journal of Biomedical Nanotechnology, 14, 456–476.
Lee, J. S., Kallehauge, T. B., Pedersen, L. E., & Kildegaard, H. F. (2015). Site-specific integration in CHO cells mediated by CRISPR/Cas9 and homology-directed DNA repair pathway. Scientific Reports, 5, 8572.
Zhang, J. H., Adikaram, P., Pandey, M., Genis, A., & Simonds, W. F. (2016). Optimization of genome editing through CRISPR-Cas9 engineering. Bioengineered, 7, 166–174.
Dang, Y., Jia, G., Choi, J., Ma, H., Anaya, E., Ye, C., et al. (2015). optimizing sgRNA structure to improve CRISPR-Cas9 knockout efficiency. Genome Biology, 16, 280.
Acknowledgements
The authors were financially supported by the National Natural Science Foundation of China (Grant No. 81801754), the Second Affiliated Hospital of Soochow University Preponderant Clinic Discipline Group project funding (Grant No. XKQ2015009), Jiangsu Province Youth medical talent support program (Grant No. QNRC2016868), the Suzhou Science and Technology Planning Project (Grant No. SYS201727). In addition, Professor Li Kai has provided a great help to this supplementary experiment and the modification of the article. We were appreciated for his help very much.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wei, C., Chen, T., Zhang, Y. et al. A Novel White-to-Blue Colony Formation Assay to Select for Optimized sgRNAs. Mol Biotechnol 63, 1–12 (2021). https://doi.org/10.1007/s12033-020-00280-w
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12033-020-00280-w